Product Program year 2025 Source: CMS Open Payments

Anktiva

Drug Immunotherapy

NDC 81481-803-01

Open in the dashboard

General payments

$347,009

4,369 payments

Research payments

$0

0 payments

Through program year 2025, $347,009 in general payments and $0 in research payments were reported against Anktiva (Immunotherapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $347,009 4,369

Breakdown

Who paid General payments · program year 2025
  1. Immunitybio, Inc. $347,009 4,369 payments
Top recipients General payments · program year 2025
  1. Christopher Pieczonka Urology · Syracuse, NY $74,969 22% · 20 payments
  2. Steven Finkelstein Gastroenterology · New York, NY $18,376 5% · 4 payments
  3. Gautam Jayram Urology · Nashville, TN $15,318 4% · 12 payments
  4. Vahan Kassabian Urology · Roswell, GA $9,076 3% · 6 payments
  5. Sam Chang Urology · Nashville, TN $7,967 2% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $244,319 71% · 1,503 practitioners
  2. Hematology & Oncology Internal Medicine $20,348 6% · 19 practitioners
  3. Gastroenterology Internal Medicine $18,376 5% · 1 practitioner
  4. Physician Assistant $12,918 4% · 287 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $11,050 3% · 250 practitioners

The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $105,800 30% · 151 recipients
  2. California $31,413 9% · 271 recipients
  3. Tennessee $30,204 9% · 61 recipients
  4. Florida $20,021 6% · 217 recipients
  5. Maryland $17,433 5% · 133 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,369 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record